Article
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays
2023-08-25
Abstract excerpt
<h4>Background</h4> Increased levels of glial fibrillary acidic protein (GFAP) in blood have been identified as a valuable biomarker for some neurological disorders, such as Alzheimer’s disease and multiple sclerosis. However, most blood GFAP quantifications so far were performed using the same bead-based assay, and to date a routine clinical application is lacking. <h4>Methods</h4> In this study, we validated a n...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4b292a70-7bdf-5eff-8072-10a57009f2e5
- DOI
- 10.1101/2023.08.24.23294528
